Bristol-Myers Expects Strong 2013
BioPharma company Bristol-Myers Squibb expects non-GAAP earnings of at least $1.95 a share for 2013, saying that it is "well-positioned to deliver on the promise of our pipeline."
NEW YORK (
) -- Pharmaceutical company
Bristol-Myers Squibb
(BMY) - Get Report
expects non-GAAP earnings of at least $1.95 a share for 2013, saying that it is "well-positioned to deliver on the promise of our pipeline."
Bristol-Myers Squibb also expects 2013 to be the first full year of impact from the loss of its Plavix patent exclusivity in the U.S., it said in a statement. However, the company expects to sustain growth in 2014 and beyond.
The 2013 figure excludes any potential impact of U.S. healthcare reform.
-- Reported by Andrea Tse in New York
Follow TheStreet.com on
and become a fan on
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
